Cecal cancer with essential thrombocythemia treated by laparoscopic ileocecal resection: a case report

[1]  Y. Kanakura,et al.  A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia , 2018, International Journal of Hematology.

[2]  Yi Zhu,et al.  Abdominal surgery in patients with essential thrombocythemia , 2017, Medicine.

[3]  Sonia S Anand,et al.  Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia , 2017, Annals of Internal Medicine.

[4]  H. Osugi,et al.  A case of video-assisted thoracoscopic radical esophagectomy for cancer in a patient with essential thrombocythemia , 2016, Esophagus.

[5]  Xiaofeng Wang,et al.  Incidence of Postoperative Venous Thromboembolism After Laparoscopic Versus Open Colorectal Cancer Surgery: A Meta-Analysis , 2013, Surgical laparoscopy, endoscopy & percutaneous techniques.

[6]  E. Saad,et al.  Literature review and practical aspects on the management of oxaliplatin-associated toxicity. , 2012, Clinical colorectal cancer.

[7]  T. Barbui,et al.  Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. , 2008, Blood.

[8]  C. Ko,et al.  A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving Quality , 2007, Annals of Surgical Oncology.

[9]  Riva,et al.  No treatment for low‐risk thrombocythaemia:results from a prospective study , 1998, British journal of haematology.

[10]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..